Chengguo B. Li - Publications

Impact of low density lipoprotein cholesterol on the risk of gastrointestinal cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 05, 2026

Prognostic value of Naples prognostic score for locally advanced gastric cancer after neoadjuvant chemoimmunotherapy.

Journal: Future oncology (London, England)

Published: July 12, 2025

Preoperative serum magnesium level as a prognostic and predictive biomarker in locally advanced gastric cancer patients receiving neoadjuvant immunochemotherapy.

Journal: World journal of surgical oncology

Published: May 18, 2025

Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 10, 2025

Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 16, 2024

Laparoscopic versus open surgery for rectal neuroendocrine tumors: a multicenter real-world study.

Journal: BMC cancer

Published: May 31, 2024

Local Excision Versus Radical Resection for Grade 2 Rectal Neuroendocrine Tumors: A Multicenter Propensity Score-Matched Analysis.

Journal: Diseases of the colon and rectum

Published: March 07, 2024

ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer.

Journal: Cell death discovery

Published: October 04, 2023

Long-term outcomes of 1-2 cm rectal neuroendocrine tumors after local excision or radical resection: A population-based multicenter study.

Journal: Heliyon

Published: October 01, 2023

Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study.

Journal: World journal of surgical oncology

Published: June 28, 2023

Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.

Journal: Cancer science

Published: May 06, 2023

Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.

Journal: Scientific reports

Published: March 18, 2023